Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.
Baugh R. et al, (2024), J Immunother Cancer, 12
The British Society for Gene and Cell Therapy at 20 (2003–2023)
Seymour L. et al, (2024), Human Gene Therapy, 35, 5 - 8
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Wan PK-T. et al, (2023), J Immunother Cancer, 11
Optogenetically Engineered Neurons Differentiated from Human SH-SY5Y Cells Survived and Expressed ChR2 in 3D Hydrogel
Lee S-Y. et al, (2022), Biomedicines, 10, 1534 - 1534
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination.
Su W. et al, (2022), Nat Commun, 13
Deregulation of HLA-I in cancer and its central importance for immunotherapy.
Hazini A. et al, (2021), J Immunother Cancer, 9
Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.
Wan PK-T. et al, (2021), Mol Ther, 29, 1668 - 1682
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy.
Khalique H. et al, (2021), J Immunother Cancer, 9
Tackling HLA Deficiencies Head on with Oncolytic Viruses.
Fisher K. et al, (2021), Cancers (Basel), 13
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response.
Baugh R. et al, (2020), Cancers (Basel), 12
Development of a novel mammalian display system for selection of antibodies against membrane proteins.
Robertson N. et al, (2020), J Biol Chem
A Complete "Self-Repressing" Adenovirus System Enables Efficient Manufacture of Adeno-Associated Viral Vectors without Contamination by Adenovirus or Small Drugs
Su W. et al, (2020), MOLECULAR THERAPY, 28, 240 - 240
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion.
Yousaf I. et al, (2020), Cancers (Basel), 12
External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase.
Pokrovska TD. et al, (2020), Cancers (Basel), 12
Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.
Lynn GM. et al, (2020), Nat Biotechnol, 38, 320 - 332
The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy
Dyer A. et al, (2020), Cytokine and Growth Factor Reviews
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation.
Taverner WK. et al, (2019), Mol Ther Oncolytics, 15, 117 - 130
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Scott EM. et al, (2019), J Immunother Cancer, 7